TY - JOUR
T1 - Update on the challenges of treating burning mouth syndrome
AU - Suhartono, Michelle
AU - Audrey, Natasha Winona
AU - Mawantari, Tata Prasantat
AU - Hadinata, Auryn Thania Song
AU - Amani, Chininta Oktora
AU - Wicaksono, Satutya
AU - Agustina, Prisca
AU - Hanif, Hilmy Irsyadi
AU - Setiyana, Viola Stevy
AU - Anggraeni, Rizkia Putri
AU - Winias, Saka
N1 - Publisher Copyright:
© 2020 Connect Journal.
PY - 2020
Y1 - 2020
N2 - Burning Mouth Syndrome (BMS), an idiopathic oral disease and also neuropathy of trigeminal nerves appear in oral cavity with the burning sensation in tongue. Other presentation of BMS as its synonyms sore mouth, sore tongue, oral dysesthesia and scalding of mouth. This chronic debilitating oral condition has an obscure aetiology and pathogenesis, causing an abroad way to treat this disease. The medication for BMS must concern its local or systemic condition, which focusing on the relief of symptoms so the clinicians may able to improving the patients quality of life. The literature contains the summary of type drugs and supplements. Although effective therapies have been conducted in many concrete cases, a treatment modality offering efficacy in most cases of BMS, yet remains to be established. It is important to achieve an intensive knowledge to the physiopathological mechanism of BMS, and to compare and establish for developing drugs to improve the efficacy and safety profiles in the treatment of BMS.
AB - Burning Mouth Syndrome (BMS), an idiopathic oral disease and also neuropathy of trigeminal nerves appear in oral cavity with the burning sensation in tongue. Other presentation of BMS as its synonyms sore mouth, sore tongue, oral dysesthesia and scalding of mouth. This chronic debilitating oral condition has an obscure aetiology and pathogenesis, causing an abroad way to treat this disease. The medication for BMS must concern its local or systemic condition, which focusing on the relief of symptoms so the clinicians may able to improving the patients quality of life. The literature contains the summary of type drugs and supplements. Although effective therapies have been conducted in many concrete cases, a treatment modality offering efficacy in most cases of BMS, yet remains to be established. It is important to achieve an intensive knowledge to the physiopathological mechanism of BMS, and to compare and establish for developing drugs to improve the efficacy and safety profiles in the treatment of BMS.
KW - Burning mouth syndrome
KW - Clonazepam
KW - Orofacial pain
KW - Vitamin B complex
UR - http://www.scopus.com/inward/record.url?scp=85090547505&partnerID=8YFLogxK
U2 - 10.35124/bca.2020.20.S1.2943
DO - 10.35124/bca.2020.20.S1.2943
M3 - Article
AN - SCOPUS:85090547505
SN - 0972-5075
VL - 20
SP - 2943
EP - 2950
JO - Biochemical and Cellular Archives
JF - Biochemical and Cellular Archives
ER -